158 related articles for article (PubMed ID: 9079677)
41. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
[TBL] [Abstract][Full Text] [Related]
42. Association of focal adhesion kinase with Grb7 and its role in cell migration.
Han DC; Guan JL
J Biol Chem; 1999 Aug; 274(34):24425-30. PubMed ID: 10446223
[TBL] [Abstract][Full Text] [Related]
43. Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target.
Watson GM; Gunzburg MJ; Ambaye ND; Lucas WA; Traore DA; Kulkarni K; Cergol KM; Payne RJ; Panjikar S; Pero SC; Perlmutter P; Wilce MC; Wilce JA
J Med Chem; 2015 Oct; 58(19):7707-18. PubMed ID: 26359549
[TBL] [Abstract][Full Text] [Related]
44. Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.
Oligino L; Lung FD; Sastry L; Bigelow J; Cao T; Curran M; Burke TR; Wang S; Krag D; Roller PP; King CR
J Biol Chem; 1997 Nov; 272(46):29046-52. PubMed ID: 9360978
[TBL] [Abstract][Full Text] [Related]
45. Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist.
Ambaye ND; Gunzburg MJ; Traore DA; Del Borgo MP; Perlmutter P; Wilce MC; Wilce JA
Acta Crystallogr F Struct Biol Commun; 2014 Feb; 70(Pt 2):182-6. PubMed ID: 24637751
[TBL] [Abstract][Full Text] [Related]
46. Structural requirements for Tyr in the consensus sequence Y-E-N of a novel nonphosphorylated inhibitor to the Grb2-SH2 domain.
Long YQ; Yao ZJ; Voigt JH; Lung FD; Luo JH; Burke TR; King CR; Yang D; Roller PP
Biochem Biophys Res Commun; 1999 Nov; 264(3):902-8. PubMed ID: 10544028
[TBL] [Abstract][Full Text] [Related]
47. Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma.
Tanaka S; Mori M; Akiyoshi T; Tanaka Y; Mafune K; Wands JR; Sugimachi K
Cancer Res; 1997 Jan; 57(1):28-31. PubMed ID: 8988034
[TBL] [Abstract][Full Text] [Related]
48. Single phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high-affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ-RGS3 protein.
Su Z; Xu P; Ni F
Eur J Biochem; 2004 May; 271(9):1725-36. PubMed ID: 15096211
[TBL] [Abstract][Full Text] [Related]
49. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
[TBL] [Abstract][Full Text] [Related]
50. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of FGF receptor signalling in Xenopus oocytes: differential effect of Grb7, Grb10 and Grb14.
Cailliau K; Le Marcis V; Béréziat V; Perdereau D; Cariou B; Vilain JP; Burnol AF; Browaeys-Poly E
FEBS Lett; 2003 Jul; 548(1-3):43-8. PubMed ID: 12885405
[TBL] [Abstract][Full Text] [Related]
52. Adaptor signalling proteins Grb2 and Grb7 are recruited by human G6f, a novel member of the immunoglobulin superfamily encoded in the MHC.
De Vet EC; Aguado B; Campbell RD
Biochem J; 2003 Oct; 375(Pt 1):207-13. PubMed ID: 12852788
[TBL] [Abstract][Full Text] [Related]
53. Beta-tubulin binds Src homology 2 domains through a region different from the tyrosine-phosphorylated protein-recognizing site.
Itoh T; Miura K; Miki H; Takenawa T
J Biol Chem; 1996 Nov; 271(44):27931-5. PubMed ID: 8910394
[TBL] [Abstract][Full Text] [Related]
54. Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression.
Ambaye ND; Pero SC; Gunzburg MJ; Yap M; Clayton DJ; Del Borgo MP; Perlmutter P; Aguilar MI; Shukla GS; Peletskaya E; Cookson MM; Krag DN; Wilce MC; Wilce JA
J Mol Biol; 2011 Sep; 412(3):397-411. PubMed ID: 21802427
[TBL] [Abstract][Full Text] [Related]
55. The Grb7 family of signalling proteins.
Daly RJ
Cell Signal; 1998 Oct; 10(9):613-8. PubMed ID: 9794242
[TBL] [Abstract][Full Text] [Related]
56. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
Gram H; Schmitz R; Zuber JF; Baumann G
Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity.
Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA
Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265
[TBL] [Abstract][Full Text] [Related]
58. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
59. Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target.
Watson GM; Kulkarni K; Sang J; Ma X; Gunzburg MJ; Perlmutter P; Wilce MCJ; Wilce JA
J Med Chem; 2017 Nov; 60(22):9349-9359. PubMed ID: 29083893
[TBL] [Abstract][Full Text] [Related]
60. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
